Safety and Efficacy of Combination Therapy of Upadacitinib and Biologic Agents for Treatment-Resistant Psoriasis and Psoriatic Arthritis. J of Skin 2024, 8 (3), 1574-1580. https://doi.org/10.25251/skin.8.3.17.